Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin

Lonza Group AG / Key word: Annual Results

Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin
26-Jan-2024 / 06:50 CET/CEST

Release of an ad hoc...

Related Keywords

Switzerland ,Visp ,Switzerland General ,China ,Guangzhou ,Guangdong ,Swiss ,Albertm Baehny , ,Capsules Health Ingredients ,European Union ,Small Molecules ,Power Purchase Agreements ,Mid Term Guidance ,Annual General Meeting ,Markets ,